Identification of a Splenic Marginal Zone Lymphoma Signature: Preliminary Findings With Diagnostic Potential

Splenic marginal zone lymphoma (SMZL) is a rare, indolent non-Hodgkin's lymphoma that affects 0. 13 per 100,000 persons annually. Overall survival of SMZL is estimated to reach 8–11 years in most cases, but up to 30% of SMZL cases develop aggressive presentations resulting in greatly diminished...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Jacob E., Greiner, Timothy C., Bouska, Alyssa C., Iqbal, Javeed, Cutucache, Christine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225304/
https://www.ncbi.nlm.nih.gov/pubmed/32457837
http://dx.doi.org/10.3389/fonc.2020.00640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225304/
https://www.ncbi.nlm.nih.gov/pubmed/32457837
http://dx.doi.org/10.3389/fonc.2020.00640

Ejemplares similares